Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy

European Journal of Heart Failure

Volumn 8, Issue 2, 2006, Pages 179-186

  Pitzalis, Maria Vittoria ^b   Hamlyn, John M ^c   Messaggio, Elisabetta ^a   Iacoviello, Massimo ^b   Forleo, Cinzia ^b   Romito, Roberta ^b   De Tommasi, Elisabetta ^b   Rizzon, Paolo ^b   Bianchi, Giuseppe ^a   Manunta, Paolo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac failure; Na pump; Ouabain like factor; Progression

Indexed keywords

OUABAIN;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL FEATURE; FEMALE; FOLLOW UP; HEART FAILURE; HEART GRAFT; HOSPITALIZATION; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS;

ANALYSIS OF VARIANCE; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; EXERCISE TEST; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; OUABAIN; OXYGEN CONSUMPTION; PROGNOSIS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; STROKE VOLUME;

EID: 32644438647     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.07.010     Document Type: Article

References (41)

1. D.L. Mann Mechanism and models in heart failure. A combinatorial approach Circulation 100 1999 999 1008
2. S.S. Gottlieb, A.C. Rogowski, M. Weinberg, C.M. Krichten, B.P. Hamilton, and J. Hamlyn Elevated concentrations of endogenous ouabain in patients with congestive heart failure Circulation 86 1992 420 425
3. F.H. Leenen, B.S. Huang, H. Yu, and B. Yuan Brain 'ouabain' mediates sympathetic hyperactivity in congestive heart failure Circ Res 77 1995 993 1000
4. J.M. Hamlyn, M.P. Blaustein, and S. Bova Identification and characterization of a ouabain-like compound from human plasma Proc Natl Acad Sci U S A 88 1991 6259 6266
5. P. Manunta, E. Messaggio, C. Ballabeni, M.T. Sciarrone, C. Lanzani, and M. Ferrandi Salt Sensitivity Study Group of the Italian Society of Hypertension. Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension Hypertension 38 2001 198 203
6. J.G. Wang, J.A. Staessen, E. Messaggio, T. Nawrot, R. Fagard, and J.M. Hamlyn Salt, endogenous ouabain and blood pressure interactions in the general population J Hypertens 21 2003 1475 1481
7. M. Ferrandi, and P. Manunta Ouabain-like factor: is this the natriuretic hormone? Curr Opin Nephrol Hypertens 9 2000 165 171
8. M. Ferrandi, I. Molinari, P. Barassi, E. Minotti, G. Bianchi, and P. Ferrari Organ hypertrophic signalling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238 J Biol Chem 279 2004 33306 33314
9. P. Manunta, P. Stella, R. Rivera, D. Ciurlino, D. Cusi, and M. Ferrandi Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension Hypertension 34 1999 450 456
10. S.D. Pierdomenico, A. Bucci, P. Manunta, R. Rivera, M. Ferrandi, and J.M. Hamlyn Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension Am J Hypertens 14 2001 44 50
11. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies Circulation 93 1996 841 842
12. N.B. Shiller, P.M. Shah, and M. Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography J Am Soc Echocardiogr 2 1989 358 367
13. M. Ferrandi, P. Manunta, S. Balzan, J.M. Hamlyn, G. Bianchi, and P. Ferrari Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays Hypertension 30 1997 886 896
14. D.W. Harris, M.A. Clark, and J.F. Fisher Development of an immunoassay for endogenous digitalis-like factor Hypertension 17 6 Pt. 2 1991 936 943
15. W.S. Colucci, M. Packer, and M.R. Bristow Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group Circulation 94 1996 2800 2806
16. R. Narang, J.G. Cleland, and L. Erhardt Mode of death in chronic heart failure. A request and proposition for more accurate classification Eur Heart J 17 1996 1390 1403
17. A.A. Aileru, A. DeAlbuquerque, and J.M. Hamlyn Synaptic plasticity in sympathetic ganglia from acquired and inherited forms of ouabain-dependent hypertension Am J Physiol Regul Integr Comp Physiol 281 2001 R635 R644
18. A.S. Budzikowski, B.S. Huang, and F.H. Leenen Brain "ouabain", a neurosteroid, mediates sympathetic hyperactivity in salt-sensitive hypertension Clin Exp Hypertens 20 1998 119 140
19. T. Yamazaki, T. Akiyama, and T. Kawada Effects of ouabain on in situ cardiac sympathetic nerve endings Neurochem Int 35 1999 439 445
20. J. Zhang, and F.H. Leenen AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline Am J Physiol Heart Circ Physiol 280 3 2001 H1318 H1323
21. F.H. Leenen, B. Yuan, and B.S. Huang Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction Am J Physiol 2 1999 H1786 H1792
22. W.J. Paulus Cytokines and heart failure Heart Fail Monit 1 2000 50 56
23. A. Matsumori, K. Ono, and R. Nishio Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain Circulation 96 1997 1501 1506
24. M. Packer The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 20 1992 248 254
25. The Digitalis Investigation Group The effect of digoxin on morbidity and mortality in patients with heart failure N Eng J Med 336 1997 525 533
26. R. Selden, M.N. Margolies, and T.W. Smith Renal and gastrointestinal excretion of ouabain in dog and man J Pharmacol Exp Ther 188 1974 615 623
27. S. St George, M. Friedman, and T. Ishida The renal excretion of digoxin in the normal young subject J Clin Invest 37 1958 836 837
28. Y. Tanigawara Role of p-glycoprotein in drug disposition Ther Drug Monit 22 2000 137 140
29. T. Mikkaichi, T. Suzuki, T. Onogawa, T. Tanemoto, H. Mizutamari, and M. Okada Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney Proc Natl Acad Sci U S A 101 2004 3569 3574
30. J. Laredo, B.P. Hamilton, and J.M. Hamlyn Ouabain is secreted by bovine adrenocortical cells Endocrinology 135 1994 794 797
31. S.A. Jortani, S.D. Prabbu, and R. Valdes Jr. Strategies for developing biomarkers of heart failure Clin Chem 502 2004 265 278
32. J.A. Doust, E. Piertrzak, A. Dobson, and P. Glasziou How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review BMJ 330 2005 625 634
33. A.M. Richards, R. Doughty, and G. Nicholls Plasma N-terminal Pro-brain Natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group J Am Coll Cardiol 37 2001 1781 1787
34. Y. Hamada, N. Tanaka, and K. Murata Significance of predischarge BNP on one-year outcome in decompensated heart failure-comparative study with echo-Doppler indexes J Card Fail 11 2005 43 49
35. T. Tsutamoto, A. Wada, and K. Maeda Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure Am Heart J 1 1997 910 916
36. P. Ferrari, L. Torielli, M. Ferrandi, G. Padoani, L. Duzzi, and M. Florio PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain J Pharmacol Exp Ther 285 1998 83 94
37. B.S. Huang, and F.H. Leenen Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats Hypertension 34 1999 107 112
38. F.H. Leenen, B. Yuan, and B.S. Huang Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction Am J Physiol 2 1999 H1786 H1792
39. B.S. Huang, B. Yuan, and F.H. Leenen Chronic blockade of brain "ouabain" prevents sympathetic hyper-reactivity and impairment of acute baroreflex resetting in rats with congestive heart failure Can J Physiol Pharmacol 78 2000 45 53
40. W.R. Mathews, D.W. DuCharme, and J.M. Hamlyn Mass spectral characterization of an endogenous digitalislike factor from human plasma Hypertension 17 1991 930 935
41. P. Manunta, M. Lacoviello, and C. Forleo High circulating levels of endogenous ouabain in the offspring of hypertensive and normotensive individuals J Hypertens 23 9 2005 Sep 1677 1681